The largest database of trusted experimental protocols

157 protocols using ab182651

1

Lipid Metabolism Assessment in Mice

Check if the same lab product or an alternative is used in the 5 most similar protocols
Kits for assessing total cholesterol (TC, 7007210506), triglycerides (TG, 7006210506), low-density lipoprotein cholesterol (LDL-C, 7021220605), and high-density lipoprotein cholesterol (HDL-C, 7020210506) in mouse serum were purchased from Yingkexinchuang Science and Technology Ltd. (Xiamen, China). Antibodies against Beclin1 (ab62557, ab207612), LC3II protein kinase B (ab48394, ab192890), pan-Akt, (ab8805), PI3K (ab182651), anti-phosphorylated (p)-PI3Kp85 (ab182651), anti-p-AKT1 (S473) (ab18206) mTOR (ab32028), p-mTORC1 (Ser2448) (ab109268), and Atg13 (ab105392) were purchased from Abcam (Cambridge, UK). LY294002 (HY-10108), Triciribine (HY-15457), and Rapamycin (HY-10219) were purchased from Med Chem Express (New Jersey, USA). Kits for assessing TC and free cholesterol (FC) (E1015 and E1016) in macrophages were purchased from Applygen Technologies Inc. (Beijing, China). SYDC was provided by the manufacturing laboratory of Beijing Tradition Chinese Medicine Hospital (Beijing, China; Z20053327). Lipitor (atorvastatin calcium) was purchased from Pfizer Pharmaceutical Co., Ltd (Shanghai, China; H20051408).
+ Open protocol
+ Expand
2

Serum Protein Quantification and Analysis

Check if the same lab product or an alternative is used in the 5 most similar protocols
Total serum protein was quantified using a Pierce™ BCA protein quantification kit (Thermo, San Jose, CA, USA), and all samples diluted to 2 μg prot/µL. Samples were denatured in a 100 °C metal bath for 15 min with a protein loading buffer (Epizyme, Shanghai, China) for further analysis. Sodium dodecyl sulfate–polyacrylamide gel electrophoresis from 80 V to 120 V and electric transfer at 250 mA were performed after the addition of 2.5 μL marker (Fisher, San Jose, CA, USA) and 20 μg serum samples. Subsequently, membranes were blocked with a rapid blocking solution (Genefist, Oxfordshire, UK) for 10 min, eluted with TBST (Solarbio, Beijing, China), and incubated with primary antibodies specific for p-PI3K (1:1000, ab182651; Abcam), Akt (1:1000, 4691T; CST), p-Akt (1:1000, ab278565; Abcam), NF-κB p65 (1:1000, 8242T; CST), NF-κB p-p65 (1:1000, 3033S; CST) and transferrin (serum loading control, 1:10,000, ab82411; Abcam) overnight at 4 °C. Following re-elution with TBST, bands were incubated with a secondary antibody (1:5000, bs-40295G-HRP; Bioss) for 2 h. Finally, the strips were evenly coated with ECL developer solution (US Everbright, Suzhou, China) and visualized using the Tanon 5200 Multi fully automated chemiluminescence image analysis system (Tanon, Shanghai, China).
+ Open protocol
+ Expand
3

Protein Secretion in Mesenchymal Stem Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
The protein secretion of PI3 kinase p85 (PI3K), phospho-PI3K (p-PI3K), heme oxygenase 1 (HO-1) and indoleamine 2,3-dioxygenase (IDO) in cultured mesenchymal stem cells according to the experimental procedures were detected by western blot assay.
Adherent cells were scraped from the culture dishes, and total protein was extracted from the cell pellet with RIPA lysis buffer (89,900, Thermo Scientific). The proteins were separated through a 12% sodium dodecyl sulfate-polyacrylamide gel electrophoresis and transferred to polyvinylidene difluoride membranes (ISEQ00010, Merck Millipore). The membrane was blocked and probed with primary antibodies overnight, including PI3 kinase p85 (PI3K, ab133595, abcam), phospho-PI3K (p-PI3K, ab182651, abcam), heme oxygenase 1 (HO-1, ab68477, abcam), indoleamine 2,3-dioxygenase (IDO, ab277522, abcam) and β-Actin (ab8226, abcam) at 1:1,000 dilutions. The membrane was then incubated with the secondary antibodies (115-035-003, Jackson). The signals were scanned for the densitometry and the final blots were quantified with ImageJ Version 2.1.0/1.53c software.
+ Open protocol
+ Expand
4

Immunohistochemical Profiling of Liver Cancer Xenografts

Check if the same lab product or an alternative is used in the 5 most similar protocols
The tumor sections of liver cancer xenografts from nude mice (5 μm thick) were stained with anti-PI3K antibody (1:1000; ab182651; Abcam), anti-p-AKT (1:500; ab8933; Abcam), Cleaved Cas-3 (1:20; ab2302, Abcam) and anti-Ki67 antibody (1:500; ab15580; Abcam) at 4°C overnight, and then reacted with anti-IgG secondary antibody (1:1000; ab6721; Abcam) for 30 min. 3,3-diaminodiphenylamine (DAB, DA1010, Solarbio, Beijing, China) was used for visualization. Five fields of 200× magnification were randomly captured at each repeat using an inverted microscope (Nikon, Tokyo, Japan).
+ Open protocol
+ Expand
5

Western Blot Analysis of IL-7, PI3K, and AKT Signaling

Check if the same lab product or an alternative is used in the 5 most similar protocols
The A549/DDP cell line or tumor tissues were rinsed with PBS and lysed in a RIPA buffer with protease inhibitors and phosphatase inhibitors (Roche Applied Science, Indianapolis, IN, USA) for Western blots. The proteins were segregated from tumor samples or cell lines. Procedures for immunoblotting are described elsewhere [18 (link)]. Primary antibodies against IL-7 (Abcam, ab9732, 1 : 3000 dilution), IL-7R (Abcam, ab180521, 1 : 1000 dilution), PI3K (CST, 13666, 1 : 1000 dilution), p-PI3K p85 alpha (phospho Y607) (Abcam, ab182651, 1 : 1000 dilution), AKT (CST, 4691, 1 : 1000 dilution), p-AKT (CST, 4691, 1 : 2000 dilution), ABCG2 (Abcam, ab130244, 1 : 1000 dilution), and GAPDH (Abcam, ab181602, 1 : 10000 dilution), as well as HRP-conjugated goat anti-rabbit secondary antibodies (Abcam, ab7090, 1 : 10000 dilution) and HRP-conjugated goat anti-mouse secondary antibodies (Abcam, ab47827, 1 : 5000 dilution), were procured from Abcam (Cambridge, MA, USA) or Cell Signaling Technology (Denver, MA).
+ Open protocol
+ Expand
6

Protein Expression Analysis of Rat Endometrium

Check if the same lab product or an alternative is used in the 5 most similar protocols
Rat endometrium tissues were initially homogenized and lysed in radio-immunoprecipitation assay (RIPA) buffer (Beijing Dingguo Changsheng Biotechnology Co. Ltd., China) supplemented with proteinase inhibitor (Lot#4693116001, Roche). Lysates were then centrifuged for 20 min at 12,000 g. The bicinchoninic acid (BCA) (Beijing Dingguo Changsheng Biotechnology Co. Ltd., China) was used for quantification of protein concentration. Equivalent amounts of protein (20 μg) were then used for western blot with primary antibodies of VEGF (ab53465, Abcam, UK), PI3K (ab191606, Abcam, UK), P-PI3K (ab182651, Abcam, UK), AKT (ab8805, Abcam, UK), P-AKT (ab38449, Abcam, UK), Ang-1 (ab102015, Abcam, UK), Ang-2 (ab155106, Abcam, UK) and HIF-1a (ab1, Abcam, UK) at 4 °C with gentle shaking overnight. After washing with TBS-T for three times, the membranes were then incubated with the secondary antibody at RT for 1 h and detected using an ECL plus kit (Beijing Dingguo Changsheng Biotechnology Co. Ltd., China). The ECL signals were detected with Quantity One software (Bio-Rad, Hercules, CA) and blot intensities were quantified by using imageJ (NIH, Bethesda, MD) software. Tubulin (ab8245, Abcam, UK) was used as an internal control to validate the amount of protein loaded onto the gels.
+ Open protocol
+ Expand
7

Analyzing Lidocaine's Impact on U87 Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
Following treatment of U87 cells with Lid-FA-Lip (1 mM lidocaine, 37˚C for 24 h), total protein was extracted with RIPA buffer (Beyotime Institute of Biotechnology) and protein determination was performed using the BCA method. Protein samples (10 µg loaded per lane) were separated on 10% SDS-PAGE and transferred onto PVDF membranes (250 mA; 2 h), which were then blocked with 5% milk in TBS with 0.05% Tween-20 at 25˚C for 2 h. The PVDF membranes were subsequently treated with primary antibodies targeting the following proteins (all from Abcam): Bcl-2 (ab32124; dilution, 1:500), matrix metalloproteinase 2 (MMP2; ab92536; dilution, 1:500), Ki67 (ab92742; dilution, 1:1,000), phosphorylated (p-)PI3Kp85 (phospho Y607; ab182651; dilution, 1:1,000), PI3Kp85 (ab135253; dilution, 1:500), p-AKT (phospho T308; ab38449; dilution, 1:1,000), AKT (ab18785; dilution, 1:1,000) and GAPDH (ab8245; dilution, 1:3,000) at room temperature for 2 h. The membranes were then incubated with anti-rabbit (cat. no. ab6271; Abcam) or anti-mouse (cat. no. ab6728; Abcam) HRP-conjugated secondary antibodies (1:5,000 dilution) at room temperature for 1 h. Signals were then visualized using an ECL kit (Novex™ ECL Chemiluminescent Substrate Reagent kit; Thermo Fisher Scientific, Inc.) and visualized by ImageJ 8.0 software (National Institutes of Health).
+ Open protocol
+ Expand
8

Quantification of Apoptosis-Related Proteins

Check if the same lab product or an alternative is used in the 5 most similar protocols
Cells were lysed in RIPA Lysis Buffer and a BCA Protein Assay kit (Thermo Fisher Scientific) was used to determine the protein concentration. Proteins of each sample were separated by SDS-PAGE gel. Then, the proteins were transferred onto a polyvinylidene fluoride membrane (Millipore, Billerica, MA, USA). After that, the membranes were blocked with 5% non-fat milk, followed by the incubation with primary antibodies at 4°C overnight: anti-Bax (Abcam; ab32503) (1:1000), anti-active caspase 3 (Abcam; ab2302) (1:1000), anti-Bcl-2 (Abcam; ab32124) (1:1000), anti-β-actin (Abcam; ab8227) (1:1000), anti-PTEN (Abcam; ab32199) (1:1000), anti-p-PI3K p85 (p-p85, Abcam; ab182651) (1:1000), anti-p-Akt (Abcam; ab38449) (1:1000). The membranes were washed in TBST three times then incubated with secondary antibodies for 1 hr at room temperature. Chemiluminescence (Millipore Corporation, Billerica, MA, USA) were applied to measure protein expression using densitometry analysis (ImageJ software).
+ Open protocol
+ Expand
9

Quantitative Western Blot Analysis

Check if the same lab product or an alternative is used in the 5 most similar protocols
Western blot (WB) was carried out as our previous method.44 (link), 45 (link), 55 (link) The following primary antibodies were applied: Ser536p‐NF‐κB p65 (Cat. No.: #3033), NF‐κB p65 (Cat. No.: #8242), Ser473p‐Akt (Cat. No.: #4060), Akt (Cat. No.: #9272), Bax (Cat. No.: #2772), cleaved caspase‐3 (Cat. No.: #9664) (1:1000, CST, Danvers, MA, USA), Bcl‐2 (Cat. No.: ab59348, 1:500, Abcam), Tyr607p‐PI3K (Cat. No.: ab182651, 1:1000, Abcam), and PI3K (Cat. No.: BSM‐33219 M, 1:1000, Bioss, Beijing, China). β‐actin (Cat. No.: ab8227, 1:1000, Abcam) and Lamin A (Cat. No.: ab26300, 1:3000, Abcam) were employed as the internal reference. WB protein bands were quantified by ImageJ software (National Institutes of Health, Baltimore, MD, USA). Protein expression levels were indicated by the ratio of interest protein bands to that of β‐actin or Lamin A bands.
+ Open protocol
+ Expand
10

Autophagy Pathway Regulation Assay

Check if the same lab product or an alternative is used in the 5 most similar protocols
AS-IV (HPLC ≥ 98.81%) and fine particulate matter standards were respectively purchased from Chengdu Munster Company (China) and National Institute of Standards and Technology (USA). 3-Methyladenine (3-MA) was purchased from Selleck, and polyvinylidene fluoride membranes were purchased from Bio-Rad (USA). Antibodies against the following targets were obtained from Abcam (Cambridge, UK): LC3B (ab48394), p62 (ab56416), PI3K (ab182651), Akt (ab185633), p-Akt (ab38449), mTOR (ab2732), p-mTOR (ab137133), Lamin B (ab16048), and GAPDH (ab181602). An antibody against p-PI3K (AF3242) was obtained from Affinity Biosciences (USA). An antibody against p65 (8242S) was obtained from Cell Signaling Technology (Danvers, MA, USA). Horseradish peroxidase (HRP)-labeled goat anti-rabbit IgG secondary antibody (GB23303) and 4°C tissue radioimmunoprecipitation assay lysates were obtained from Servicebio (Wuhan, China).
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!